Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Tests and diagnosis
By Mayo Clinic staff
Test and procedures used to diagnose chronic myelogenous leukemia include:
- Physical exam. Your doctor will examine you and check such vital signs as pulse and blood pressure. He will also feel your lymph nodes, spleen and abdomen for abnormalities.
- Blood tests. A complete blood count (CBC) may reveal abnormalities in your blood cells. Blood chemistry tests to measure organ function may also reveal abnormalities that can help your doctor make a diagnosis.
- Bone marrow tests. Bone marrow biopsy and bone marrow aspiration are used to collect bone marrow samples for laboratory testing. These tests involve collecting bone marrow from your hipbone.
- Tests to look for the Philadelphia chromosome. Specialized tests, such as fluorescence in situ hybridization (FISH) analysis and polymerase chain reaction (PCR) test, analyze blood or bone marrow samples for the presence of the Philadelphia chromosome or the BCR-ABL gene.
Phases of chronic myelogenous leukemia
The phase of chronic myelogenous leukemia refers to the aggressiveness of the disease. Your doctor determines the phase by measuring the proportion of diseased cells to healthy cells in your blood or bone marrow. A higher proportion of diseased cells means chronic myelogenous leukemia is at a more advanced stage.
Phases of chronic myelogenous leukemia include:
- Chronic. The chronic phase is the earliest phase and generally has the best response to treatment.
- Accelerated. The accelerated phase is a transitional phase when the disease becomes more aggressive.
- Blastic. Blastic phase is a severe, aggressive phase that becomes life-threatening.
- Chronic myelogenous leukemia. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/cml.pdf. Accessed Sept. 11, 2008.
- Chronic myelogenous leukemia treatment (PDQ) patient version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/CML/patient/allpages/patient. Accessed Sept. 11, 2008.
- Chronic myelogenous leukemia and related disorders: An overview. In: Lichtman MA, et al. Williams Hematology. 7th ed. New York, N.Y.: McGraw-Hill; 2006. http://www.accessmedicine.com/content.aspx?aID=2148618. Accessed Sept. 11, 2008.
- Leukemia - chronic myeloid - CML. Cancer.Net. http://www.cancer.net/patient/Cancer+Types/Leukemia+-+Chronic+Myeloid+-+CML. Accessed Sept. 17, 2008.
- Integrative medicine and complementary and alternative therapies as part of blood cancer care. The Leukemia & Lymphoma Society. http://www.leukemia-lymphoma.org/attachments/National/br_1150734030.pdf. Accessed Sept. 17, 2008.
- Questions about treatment. The Leukemia & Lymphoma Society. http://www.leukemia-lymphoma.org/graphics/National/Allquestionsworksheets/QuestionsabouttreatmentPS172R.pdf. Accessed Sept. 16, 2008.
- Kantarjian H, et al. Chronic myeloid leukemia. In: Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:2279-2291.
- SEER stat fact sheets - chronic myeloid leukemia. Surveillance Epidemiology and End Results. http://seer.cancer.gov/statfacts/html/cmyl.html. Accessed Sept. 19, 2008.
- Tasignia (prescribing information). East Hanover, N.J.: Novartis; 2007.
- Gleevec (prescribing information). East Hanover, N.J.: Novartis; 2007.
- Sprycel (prescribing information). Princeton, N.J.: Bristol-Myers Squibb; 2007.
